Augmented autocrine bone morphogenic protein (BMP) 7 signaling increases the metastatic potential of mouse breast cancer cells

Clinical and Experimental Metastasis

Volumn 29, Issue 4, 2012, Pages 327-338

  Sakai, Hirofumi ^a,d   Furihata, Mutsuo ^b   Matsuda, Chie ^a   Takahashi, Munehisa ^a   Miyazaki, Hiroshi ^c   Konakahara, Takeo ^d   Imamura, Toru ^a   Okada, Tomoko ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Anchorage independent growth; BMP7; Breast caner; Metastasis; Migration

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR; NEUTRALIZING ANTIBODY; OSTEOGENIC PROTEIN 1; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; BONE MARROW CELL; BREAST CANCER; BREAST METASTASIS; CANCER CELL; CANCER MODEL; CELL ANCHORAGE; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE SILENCING; LUNG METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPINE METASTASIS; WOUND HEALING;

ANIMALS; AUTOCRINE COMMUNICATION; BONE MARROW NEOPLASMS; BONE MORPHOGENETIC PROTEIN 7; FEMALE; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; TUMOR CELLS, CULTURED;

EID: 84859717857     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-012-9453-9     Document Type: Article

References (29)

1. Takahashi M, Furihata M, Akimitsu N, Watanabe M, Kaul S, Yumoto N, Okada T (2008) A highly bone marrow metastatic murine breast cancer model established through in vivo selection exhibits enhanced anchorage-independent growth and cell migration mediated by ICAM-1. Clin Exp Metastasis 25:517-529
2. Takahashi M, Miyazaki H, Furihata M, Sakai H, Konakahara T, Watanabe M, Okada T (2009) Chemokine CCL2/MCP-1 negatively regulates metastasis in a highly bone marrow-metastatic mouse breast cancer model. Clin Exp Metastasis 26:817-828
3. Chen D, Zhao M, Mundy GR (2004) Bone morphogenetic proteins. Growth Factors 4:233-241 (Pubitemid 40136452)
4. Ye L, Lewis-Russell JM, Kyanaston HG, Jiang WG (2007) Bone morphogenetic proteins and their receptor signaling in prostate cancer. Histol Histopathol 10:1129-1147 (Pubitemid 47470307)
5. Asahina I, Sampath TK, Hauschka PV (1996) Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res 222:38-47 (Pubitemid 26043710)
6. Autzen P, Robson CN, Bjartell A, Malcolm AJ, Johnson MI, Neal DE, Hamdy FC (1998) Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies. Br J Cancer 78:1219-1223 (Pubitemid 28479155)
7. Masuda H, Fukabori Y, Nakano K, Takezawa Y, CSuzuki T, Yamanaka H (2003) Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer. Prostate 54:268-274 (Pubitemid 36228163)
8. Miyazono K, Kamiya Y, Morikawa M (2010) Bone morphogenetic protein receptors and signal transduction. J Biochem 147:35-51
9. Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K (2002) Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells 12:1191-1204 (Pubitemid 36024597)
10. Massagué J, Blain SW, Lo RS (2000) TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103:295-309
11. Asada M, Honda E, Imamura T (2006) Construction of pcDNA 3.1-based vectors with blasticidin and puromycin resistant markers. Anal Biochem 352:305-307
12. Alarmo EL, Pärssinen J, Ketolainen JM, Savinainen K, Karhu R, Kallioniemi A (2009) BMP7 influences proliferation, migration, and invasion of breast cancer cells. Cancer Lett 275:35-43
13. Ichikawa T, Suenaga Y, Koda T, Ozaki T, Nakagawara A (2008) DeltaNp63/BMP-7-dependent expression of matrilin-2 is involved in keratinocyte migration in response to wounding. Biochem Biophys Res Commun 369:994-1000
14. Rothhammer T, Braig S, Bosserhoff AK (2008) Bone morphogenetic proteins induce expression of metalloproteinases in melanoma cells and fibroblasts. Eur J Cancer 44:2526-2534
15. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R (2003) BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9:964-968 (Pubitemid 36889942)
16. Rees JR, Onwuegbusi BA, Save VE, Alderson D, Fitzgerald RC (2006) In vivo and in vitro evidence for transforming growth factor-beta1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma. Cancer Res 66:9583-9590 (Pubitemid 44623657)
17. Yang S, Zhong C, Frenkel B, Reddi AH, Roy-Burman P (2005) Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Cancer Res 65:5769-5777 (Pubitemid 40911180)
18. Rothhammer T, Poser I, Soncin F, Bataille F, Moser M, Bosserhoff AK (2005) Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res 65:448-456
19. Alarmo EL, Korhonen T, Kuukasjärvi T, Huhtala H, Holli K, Kallioniemi A (2008) Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas. Ann Oncol 19:308-314 (Pubitemid 351201712)
20. Motoyama K, Tanaka F, Kosaka Y, Mimori K, Uetake H, Inoue H, Sugihara K, Mori M (2008) Clinical significance of BMP7 in human colorectal cancer. Ann Surg Oncol 15:1530-1537
21. Rothhammer T, Wild PJ, Meyer S, Bataille F, Pauer A, Klinkhammer-Schalke M, Hein R, Hofstaedter F, Bosserhoff AK (2007) Bone morphogenetic protein 7 (BMP7) expression is a potential novel prognostic marker for recurrence in patients with primary melanoma. Cancer Biomark 3:111-117 (Pubitemid 47103812)
22. Buijs JT, Henriquez NV, van Overveld PG (2007) Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. Cancer Res 67:8742-8751 (Pubitemid 47437450)
23. Na YR, Seok SH, Kim DJ et al (2009) Bone morphogenetic protein 7 induces mesenchymal -to-epithelial transition in melanoma cells, leading to inhibition of metastasis. Cancer Sci 100:2218-2225
24. Chen J, Ye L, Xie F, Yang Y, Zhang L, Jiang WG (2010) Expression of bone morphogenetic protein 7 in lung cancer and its biological impact on lung cancer cells. Anticancer Res 4:1113-1120
25. Uruno T, Oki J, Ozawa K, Miyakawa K, Ueno H, Imamura T (1999) Distinct regulation of myoblast differentiation by intracellular and extracellular fibroblast growth factor-1. Growth Factors 17:93-113 (Pubitemid 30008811)
26. Schoner W, Scheiner-Bobis G (2007) Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol 293:C509-C536 (Pubitemid 47235171)
27. Fournier PG, Guise TA (2007) BMP7: a new bone metastases prevention? Am J Pathol 171:739-743 (Pubitemid 47440973)
28. Morrissey C, Brown LG, Pitts TE, Vessella RL, Corey E (2010) Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment. Neoplasia 12:192-205
29. Padua D, Massagué J (2009) Roles of TGFbeta in metastasis. Cell Res 19:89-102